CME Group Inc. (NASDAQ:CME) Shares Acquired by Atlanta Consulting Group Advisors LLC

Atlanta Consulting Group Advisors LLC boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 10.1% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 2,686 shares of the financial services provider’s stock after buying an additional 247 shares during the quarter. Atlanta Consulting Group Advisors LLC’s holdings in CME Group were worth $593,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the business. Wealth Enhancement Advisory Services LLC increased its holdings in shares of CME Group by 21.2% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after purchasing an additional 8,443 shares during the period. Cetera Investment Advisers boosted its stake in shares of CME Group by 429.1% during the 1st quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock valued at $10,231,000 after buying an additional 38,540 shares during the period. Brookstone Capital Management grew its holdings in shares of CME Group by 12.2% during the 2nd quarter. Brookstone Capital Management now owns 30,555 shares of the financial services provider’s stock valued at $6,156,000 after acquiring an additional 3,325 shares in the last quarter. Epoch Investment Partners Inc. increased its stake in shares of CME Group by 4.7% in the first quarter. Epoch Investment Partners Inc. now owns 99,947 shares of the financial services provider’s stock worth $21,518,000 after acquiring an additional 4,454 shares during the last quarter. Finally, Mather Group LLC. raised its holdings in shares of CME Group by 197.2% during the second quarter. Mather Group LLC. now owns 6,066 shares of the financial services provider’s stock worth $1,306,000 after acquiring an additional 4,025 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Activity at CME Group

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the transaction, the chief financial officer now owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 5.38 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Bryan T. Durkin sold 7,593 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. This trade represents a 12.01 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 over the last ninety days. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on CME. Bank of America boosted their price target on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a research note on Thursday, October 3rd. JPMorgan Chase & Co. lifted their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Oppenheimer increased their target price on shares of CME Group from $245.00 to $258.00 and gave the stock an “outperform” rating in a research report on Thursday, October 24th. TD Cowen began coverage on CME Group in a research note on Thursday, September 26th. They issued a “hold” rating and a $221.00 price objective on the stock. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $224.47.

CME Group Stock Up 0.8 %

NASDAQ CME opened at $225.28 on Monday. The company has a market cap of $81.18 billion, a price-to-earnings ratio of 23.69, a PEG ratio of 5.20 and a beta of 0.55. CME Group Inc. has a 1-year low of $190.70 and a 1-year high of $230.36. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The company has a 50 day moving average of $222.62 and a 200-day moving average of $210.39.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.65 by $0.03. The business had revenue of $1.58 billion during the quarter, compared to the consensus estimate of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. CME Group’s revenue for the quarter was up 18.4% on a year-over-year basis. During the same period in the prior year, the company earned $2.25 EPS. On average, equities research analysts expect that CME Group Inc. will post 10.22 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be given a $1.15 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.04%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.